Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Over the past three decades, the treatment of malignant central nervous system (CNS) tumors has become increasingly challenging, with only a few therapeutic ...